Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK increases health funds for bowel cancer:

This article was originally published in Clinica

Executive Summary

The UK National Health Service is aiming to improve access to diagnostic facilities for patients with bowel cancer, following an injection of £10 million ($16 million). Health authorities and hospitals will put together bids to improve services which could typically include increased use of diagnostic endoscopies. The National Screening Committee, which considers clinical evidence on population screening from research programmes, is currently considering the benefits of introducing a national screening programme for the disease. Bowel cancer causes 19,000 deaths in the UK every year.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083190

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel